Codiak BioSciences, Inc. is a clinical-stage biopharmaceutical company developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, and infectious diseases. The company has developed a platform, engEx Platform, to design, engineer, and manufacture exosome therapeutics. Its lead product candidates are exoSTING and exoIL-12 for the treatment of various solid tumors. The company was incorporated in 2015 and is headquartered in Cambridge, MA.
What is Codiak Biosciences's quote symbol?
What is the 52 week high and low for Codiak Biosciences (NASDAQ: CDAK)?
How much is Codiak Biosciences stock worth today?
How much is Codiak Biosciences's stock price per share?
What is Codiak Biosciences's Market Cap?